Projected Income Statement: WELL Health Technologies Corp.

Forecast Balance Sheet: WELL Health Technologies Corp.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - 275 244 302 341 521 446 346
Change - - -11.27% 23.77% 12.91% 52.57% -14.4% -22.42%
Announcement Date 3/18/21 3/31/22 3/21/23 3/21/24 4/15/25 - - -
1CAD in Million
Estimates

Cash Flow Forecast: WELL Health Technologies Corp.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 1.135 2.682 6.404 8.107 16.23 25.03 25.63 25.1
Change - 136.37% 138.78% 26.59% 100.15% 54.28% 2.4% -2.08%
Free Cash Flow (FCF) 1 -6.517 19.59 70.14 58.33 -6.704 84.16 96.98 123.6
Change - 400.55% 258.12% -16.84% -111.49% 1,355.37% 15.23% 27.5%
Announcement Date 3/18/21 3/31/22 3/21/23 3/21/24 4/15/25 - - -
1CAD in Million
Estimates

Forecast Financial Ratios: WELL Health Technologies Corp.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

         
EBITDA Margin (%) - -0.18% 19.97% 18.37% 14.61% 5.07% 14.26% 13.35% 13.85%
EBIT Margin (%) - -20.71% -4.23% 4.1% 4.53% -3.28% 6.16% 6.27% 7.84%
EBT Margin (%) - -13.91% -8.26% 3.15% 2.51% 0.98% 0.51% 2.62% 2.16%
Net margin (%) - -7.34% -14.48% 0.24% 0.01% 3.55% -1.16% 1.43% 3.12%
FCF margin (%) - -12.97% 6.48% 12.32% 7.52% -0.73% 6.01% 6.22% 7.4%
FCF / Net Income (%) - 176.78% -44.73% 5,123.59% 71,134.15% -20.56% -517.35% 435.82% 237.03%

Profitability

         
ROA -9.47% -2.8% 0.16% 1.59% 1.88% -0.4% - - -
ROE -36.98% -2.56% -6.67% 2.45% 2% 3.28% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - 4.55x 2.34x 2.66x 7.32x 2.61x 2.14x 1.5x
Debt / Free cash flow - - 14.02x 3.48x 5.17x -50.94x 6.19x 4.6x 2.8x

Capital Intensity

         
CAPEX / Current Assets (%) - 2.26% 0.89% 1.13% 1.04% 1.76% 1.79% 1.64% 1.5%
CAPEX / EBITDA (%) - -1,233.17% 4.44% 6.12% 7.15% 34.77% 12.52% 12.32% 10.85%
CAPEX / FCF (%) - -17.41% 13.69% 9.13% 13.9% -242.03% 29.74% 26.43% 20.3%

Items per share

         
Cash flow per share 1 - -0.0402 - - - - - - -
Change - - - - - - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - -0.03 -0.23 - - 0.13 -0.0967 0.05 0.1767
Change - - -666.67% - - - -174.36% 151.72% 253.34%
Nbr of stocks (in thousands) - 162,404 208,166 230,153 241,428 249,092 253,882 253,882 253,882
Announcement Date - 3/18/21 3/31/22 3/21/23 3/21/24 4/15/25 - - -
1CAD
Estimates
2025 *2026 *
P/E ratio -41x 79.2x
PBR - -
EV / Sales 1.09x 0.93x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
3.960CAD
Average target price
7.650CAD
Spread / Average Target
+93.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. WELL Stock
  4. Financials WELL Health Technologies Corp.